Literature DB >> 15518025

Control of Enterobacteriaceae producing extended-spectrum beta-lactamase in intensive care units: rectal screening may not be needed in non-epidemic situations.

Michelle Thouverez1, Daniel Talon, Xavier Bertrand.   

Abstract

OBJECTIVE: To evaluate the usefulness of screening cultures in the control of extended-spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae in intensive care units (ICUs).
DESIGN: A 4-year retrospective study.
SETTING: Two adult ICUs of a university-affiliated public hospital in France.
RESULTS: A total of 7,777 specimens were analyzed and 28 (0.97%) of 2,883 screened patients had a positive result on a screening test, among the 3,678 admitted patients. Thirteen of these 28 patients were only carriers; 4 were carriers and then were colonized or infected 2, 2, 3, and 8 days later, respectively; and 11 were colonized or infected before a screening test was positive. Cluster analysis showed that the occurrence of ESBL-producing Enterobacteriaceae cross-transmission within both ICUs was limited to 9 cases. Thus, most cases (19 of 28) were probably imported. Surveillance cultures failed to detect 9 of the 19 cases.
CONCLUSION: The low prevalence of ESBL-producing Enterobacteriaceae carriers on admission (0.45%) and the relative ineffectiveness of our screening test to detect imported cases suggest that systematic detection of ESBL-producing Enterobacteriaceae in ICU patients is not cost-effective and that the use of clinical cultures may be sufficient to control ESBL-producing Enterobacteriaceae in non-epidemic situations.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15518025     DOI: 10.1086/502305

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN: 0899-823X            Impact factor:   3.254


  14 in total

Review 1.  Preventing the spread of multidrug-resistant gram-negative pathogens: recommendations of an expert panel of the German Society For Hygiene and Microbiology.

Authors:  Frauke Mattner; Franz-C Bange; Elisabeth Meyer; Harald Seifert; Thomas A Wichelhaus; Iris F Chaberny
Journal:  Dtsch Arztebl Int       Date:  2012-01-20       Impact factor: 5.594

2.  Risk factors for gastrointestinal tract colonization with extended-spectrum β-lactamase (ESBL)-producing Escherichia coli and Klebsiella species in hospitalized patients.

Authors:  Jennifer H Han; Irving Nachamkin; Theoklis E Zaoutis; Susan E Coffin; Darren R Linkin; Neil O Fishman; Mark G Weiner; Baofeng Hu; Pam Tolomeo; Ebbing Lautenbach
Journal:  Infect Control Hosp Epidemiol       Date:  2012-10-23       Impact factor: 3.254

3.  Clinical impact and risk factors for colonization with extended-spectrum β-lactamase-producing bacteria in the intensive care unit.

Authors:  Keyvan Razazi; Lennie P G Derde; Marine Verachten; Patrick Legrand; Philippe Lesprit; Christian Brun-Buisson
Journal:  Intensive Care Med       Date:  2012-08-15       Impact factor: 17.440

4.  Surgical antimicrobial prophylaxis in intensive care unit (ICU) patients: a preliminary, observational, retrospective study.

Authors:  Gary Duclos; Bruno Pastene; Fanny Depeyre; Zoé Meresse; Nadim Cassir; Ignacio Martin-Loeches; Sharon Einav; Laurent Zieleskiewicz; Marc Leone
Journal:  Ann Transl Med       Date:  2018-10

5.  Targeted screening for third-generation cephalosporin-resistant Enterobacteriaceae carriage among patients admitted to intensive care units: a quasi-experimental study.

Authors:  Cédric Dananché; Thomas Bénet; Bernard Allaouchiche; Romain Hernu; Laurent Argaud; Olivier Dauwalder; François Vandenesch; Philippe Vanhems
Journal:  Crit Care       Date:  2015-02-10       Impact factor: 9.097

6.  Risk factors for colonization with extended-spectrum beta-lactamase-producing bacteria and intensive care unit admission.

Authors:  Anthony D Harris; Jessina C McGregor; Judith A Johnson; Sandra M Strauss; Anita C Moore; Harold C Standiford; Joan N Hebden; J Glenn Morris
Journal:  Emerg Infect Dis       Date:  2007-08       Impact factor: 6.883

7.  Limits of patient isolation measures to control extended-spectrum beta-lactamase-producing Enterobacteriaceae: model-based analysis of clinical data in a pediatric ward.

Authors:  Matthieu Domenech de Cellès; Jean-Ralph Zahar; Véronique Abadie; Didier Guillemot
Journal:  BMC Infect Dis       Date:  2013-04-24       Impact factor: 3.090

Review 8.  Is patient isolation the single most important measure to prevent the spread of multidrug-resistant pathogens?

Authors:  Caroline Landelle; Leonardo Pagani; Stephan Harbarth
Journal:  Virulence       Date:  2013-01-09       Impact factor: 5.882

9.  Carriage of extended-spectrum beta-lactamase-producing enterobacteriacae among internal medicine patients in Switzerland.

Authors:  Janet Pasricha; Thibaud Koessler; Stephan Harbarth; Jacques Schrenzel; Véronique Camus; Gilles Cohen; Arnaud Perrier; Didier Pittet; Anne Iten
Journal:  Antimicrob Resist Infect Control       Date:  2013-06-12       Impact factor: 4.887

10.  Rates of fecal transmission of extended-spectrum β-lactamase-producing and carbapenem-resistant Enterobacteriaceae among patients in intensive care units in Korea.

Authors:  Jayoung Kim; Ji Young Lee; Sang Il Kim; Wonkeun Song; Jae-Seok Kim; Seungwon Jung; Jin Kyung Yu; Kang Gyun Park; Yeon-Joon Park
Journal:  Ann Lab Med       Date:  2013-12-06       Impact factor: 3.464

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.